Saturday, December 16, 2017
 
 
Company News: Page (1) of 1 - 09/13/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
AgeneBio to Receive up to $10 Million in NIH Funding to Advance Program for Mild Cognitive Impairment Due to Alzheimer's Disease
Grant to support novel GABAA program targeting hippocampal overactivity that leads to neurodegeneration and cognitive decline in Alzheimer's disease patients
(September 13, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords: Inc.,Medicine,Disease,Insurance,Surgery,Medication,Childrens Health,Seniors Health,Seniors,Insurance Companies,Science,Lifestyle,Medical,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines